The Zinda framework
Pharmacogenomics
Drug-metabolism genes the standard panels were not built around.
What does this evidence grade mean?
- Verified mechanism
- Established biology; this does not validate the complete Zinda framework.
- Comparator-reframed
- The concept has been revised in light of evidence from other populations.
- Provisionally supported
- Plausible and partly supported, with further validation needed.
The idea
The enzymes that clear drugs from your body vary by ancestry, and the panels that predict drug response were largely calibrated elsewhere. A gene variant common in South Asians can turn a standard dose of a chemotherapy drug, a statin, or a blood thinner into the wrong dose, and the standard test can come back falsely reassuring because it was looking at the wrong gene. The fix is knowing which genes matter for whom.
How the evidence grades it
Every study is labeled by what it does to this concept. Counting the counterevidence is the point.
Key studies
- Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention. PMID 33357650
- UK Patients of Bangladeshi Descent with Crohn's Disease Respond Less Well to TNF Antagonists Than Caucasian Patients. PMID 31655907
← All concepts · Public summaries are open. Verified-email access adds Ask Zinda. Full dossiers require separately reviewed collaborator access.
From research to a conversation
What does this mean for you?
Research can help you ask better questions. Your health history, priorities, and care decisions deserve a conversation with a clinician.
Explore Zinda Clinic
Omar Saleem, MD
Founder & Clinical Director
South Asian health, in context.